Inicio>>6-Thioguanosine-5'-O-triphosphate (sodium salt)

6-Thioguanosine-5'-O-triphosphate (sodium salt)

Catalog No.GC90817

Un metabolito activo de la 6-tioguanina y azatioprina.

Products are for research use only. Not for human use. We do not sell to patients.

6-Thioguanosine-5'-O-triphosphate (sodium salt) Chemical Structure

Tamaño Precio Disponibilidad Cantidad
2.7 mg
454,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

6-Thioguanosine-5’-O-triphosphate (6-thio-GTP) is an active metabolite of the purine analog 6-thioguanine and the immunosuppressive purine analog azathioprine .1,2 It is formed from 6-thioguanine via 6-thio-GMP and 6-thio-GDP intermediates by phosphorylation and from azathioprine via 6-mercaptopurine , 6-thio-GMP, and 6-thio-GDP intermediates by a non-enzymatic process and several enzymatic reactions. 6-thio-GTP binds to a variety of GTPases, including Rac, Ras, Cdc42, and RhoA but selectively inhibits activation of Rac1 and Rac2 over Cdc42 in primary human CD4+ T cells stimulated with anti-CD3 and anti-CD28 antibodies.3,4 It inhibits T cell receptor-stimulated proliferation of T cells and reduces CD28-dependent T cell survival in vitro in isolated mouse splenocytes.5 6-Thio-GTP (0.5 mg/kg) increases survival in a mouse model of heart transplantation.

Reseñas

Review for 6-Thioguanosine-5'-O-triphosphate (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 6-Thioguanosine-5'-O-triphosphate (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.